Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases*

The small GTPases RalA and RalB are multifunctional proteins regulating a variety of cellular processes. Like other GTPases, the activity of Ral is regulated by the opposing effects of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Although several RalGEFs have been identified and characterized, the molecular identity of RalGAP remains unknown. Here, we report the first molecular identification of RalGAPs, which we have named RalGAP1 and RalGAP2. They are large heterodimeric complexes, each consisting of a catalytic α1 or α2 subunit and a common β subunit. These RalGAP complexes share structural and catalytic similarities with the tuberous sclerosis tumor suppressor complex, which acts as a GAP for Rheb. In vitro GTPase assays revealed that recombinant RalGAP1 accelerates the GTP hydrolysis rate of RalA by 280,000-fold. Heterodimerization was required for this GAP activity. In PC12 cells, knockdown of the β subunit led to sustained Ral activation upon epidermal growth factor stimulation, indicating that the RalGAPs identified here are critical for efficient termination of Ral activation induced by extracellular stimuli. Our identification of RalGAPs will enable further understanding of Ral signaling in many biological and pathological processes.

[1]  K. Kelly,et al.  Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone , 2007, Molecular and Cellular Biology.

[2]  P. Harris,et al.  The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. , 1997, Human molecular genetics.

[3]  Tian Xu,et al.  Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.

[4]  S. Adam,et al.  Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells , 2006, Current Biology.

[5]  E. Martegani,et al.  Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase. , 2007, Experimental cell research.

[6]  D. Geschwind,et al.  Cloning, genomic structure, and expression profiles of TULIP1 (GARNL1), a brain-expressed candidate gene for 14q13-linked neurological phenotypes, and its murine homologue. , 2004, Genomics.

[7]  Axel T Brunger,et al.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex , 2003, The EMBO journal.

[8]  A. F. Castro,et al.  Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner* , 2003, Journal of Biological Chemistry.

[9]  D. Andres,et al.  A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. , 2000, The Journal of biological chemistry.

[10]  L. Feig,et al.  Characterization of a GTPase-activating protein for the Ras-related Ral protein. , 1991, The Journal of biological chemistry.

[11]  R. Weinberg,et al.  Characterization of a guanine nucleotide dissociation stimulator for a ras‐related GTPase. , 1993, The EMBO journal.

[12]  L. J. van 't Veer,et al.  RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.

[13]  J. Camonis,et al.  Bridging Ral GTPase to Rho Pathways , 1995, The Journal of Biological Chemistry.

[14]  T. Urano,et al.  Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.

[15]  L. Quilliam,et al.  Identification and Characterization of a New Family of Guanine Nucleotide Exchange Factors for the Ras-related GTPase Ral* , 2000, The Journal of Biological Chemistry.

[16]  G. Stamp,et al.  RalGDS is required for tumor formation in a model of skin carcinogenesis. , 2005, Cancer cell.

[17]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[18]  A. Iwamatsu,et al.  The exocyst complex binds the small GTPase RalA to mediate filopodia formation , 2002, Nature Cell Biology.

[19]  S. Demo,et al.  ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.

[20]  R. Wolthuis,et al.  RalGEF2, a Pleckstrin Homology Domain Containing Guanine Nucleotide Exchange Factor for Ral* , 2000, The Journal of Biological Chemistry.

[21]  R. Wolthuis,et al.  Ras-dependent activation of the small GTPase Ral , 1998, Current Biology.

[22]  A. Wittinghofer,et al.  The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues , 2008, The EMBO journal.

[23]  M. White,et al.  Ral GTPases: corrupting the exocyst in cancer cells. , 2005, Trends in cell biology.

[24]  K. Inoki,et al.  Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity , 2004, Molecular and Cellular Biology.

[25]  M. Webb,et al.  Interaction of GTPase activating proteins (GAPs) with p21ras measured by a novel fluorescence anisotropy method. Essential role of Arg-903 of GAP in activation of GTP hydrolysis on p21ras. , 1993, The Journal of biological chemistry.

[26]  C. Der,et al.  Distinct requirements for Ras oncogenesis in human versus mouse cells. , 2002, Genes & development.

[27]  P. Crino,et al.  The tuberous sclerosis complex. , 2006, The New England journal of medicine.

[28]  I. Vetter,et al.  The GTPase-activating protein Rap1GAP uses a catalytic asparagine , 2004, Nature.

[29]  A. Wittinghofer,et al.  Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity , 1992, Molecular and cellular biology.

[30]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[31]  M. White,et al.  Ral GTPases and cancer: linchpin support of the tumorigenic platform , 2008, Nature Reviews Cancer.

[32]  O. Nureki,et al.  Regulation of Platelet Dense Granule Secretion by the Ral GTPase-Exocyst Pathway* , 2008, Journal of Biological Chemistry.

[33]  L. Feig Ral-GTPases: approaching their 15 minutes of fame. , 2003, Trends in cell biology.

[34]  S. Gridley,et al.  Adipocytes contain a novel complex similar to the tuberous sclerosis complex. , 2006, Cellular signalling.

[35]  M. White,et al.  RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival , 2003, EMBO reports.

[36]  D. Theodorescu,et al.  Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer , 2007, Clinical Cancer Research.

[37]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[38]  Alfred Wittinghofer,et al.  GEFs and GAPs: Critical Elements in the Control of Small G Proteins , 2007, Cell.

[39]  E. Hafen,et al.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.

[40]  W. Hahn,et al.  The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase , 2007, Cell.

[41]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[42]  C. Walker,et al.  Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning , 2006, The Journal of cell biology.

[43]  O. Nureki,et al.  Biochemical Characterization of the Rho GTPase-regulated Actin Assembly by Diaphanous-related Formins, mDia1 and Daam1, in Platelets* , 2008, Journal of Biological Chemistry.

[44]  C. Rossé,et al.  The exocyst is a Ral effector complex , 2002, Nature Cell Biology.

[45]  M. White,et al.  RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival , 2006, Cell.

[46]  M. Shipitsin,et al.  Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.

[47]  M. Larsen,et al.  The Brain Exocyst Complex Interacts with RalA in a GTP-dependent Manner , 2001, The Journal of Biological Chemistry.

[48]  B. Edgar,et al.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.

[49]  R. Wolthuis,et al.  Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.

[50]  S. Cantor,et al.  Identification and Characterization of Ral-Binding Protein 1, a Potential Downstream Target of Ral GTPases , 2022 .